Charbel Moussa, MD, PhD, serves as an Associate Professor of Neurology at Georgetown University Medical Center (GUMC), where he leads groundbreaking research in neurodegenerative diseases. As the director of the Translational Neurotherapeutics Program and the Laboratory for Dementia and Parkinsonism, Dr. Moussa is at the...
Charbel Moussa, MD, PhD, serves as an Associate Professor of Neurology at Georgetown University Medical Center (GUMC), where he leads groundbreaking research in neurodegenerative diseases. As the director of the Translational Neurotherapeutics Program and the Laboratory for Dementia and Parkinsonism, Dr. Moussa is at the forefront of developing innovative therapeutic strategies aimed at combating conditions such as Alzheimer’s disease and Parkinson’s disease. His expertise in molecular biology, cell biology, and biochemistry allows him to explore the intricate mechanisms underlying these disorders, paving the way for targeted drug discovery.
Dr. Moussa’s current projects focus on the identification and validation of novel biomarkers and therapeutic targets that can enhance the efficacy of treatments for neurodegenerative diseases. His laboratory employs advanced techniques such as immunohistochemistry, PCR, and Western blotting to elucidate the pathophysiological processes involved in these conditions. Through his leadership, the Translational Neurotherapeutics Program is committed to bridging the gap between laboratory research and clinical application, ensuring that scientific discoveries translate into effective therapies for patients.
In addition to his academic role, Dr. Moussa is a co-founder and director of the Scientific Advisory Board of KeiferX, a biopharmaceutical company dedicated to developing targeted therapies for neurodegenerative diseases. This dual role allows him to leverage his research insights to influence the direction of drug development in the industry. With a deep commitment to advancing the field of neurology, Dr. Moussa continues to contribute significantly to both academic research and practical applications, making a lasting impact on the lives of individuals affected by neurodegenerative disorders.
